Events & Presentations

Kamada to present at the Cantor 2018 Global Healthcare Conference

The conference is a three-day multitrack event, which will feature over 200 innovative industry leaders from public and private companies for an in-depth discussion of the developments and trends shaping biotechnology, specialty pharmaceuticals, medical technology, healthcare facilities and services, and life sciences tools and diagnostics. Kamada's CEO, Amir London,  will  present on: Wed, Oct 3 at 3:25-3:55 PM in Track 5 - Grand Ballroom 2.

Kamada to participate in ERS International Congress 2018

ERS congress is the largest meeting of respiratory professionals in the world, with an outstanding scientific and educational programme designed to address the needs of researchers, clinicians, general practitioners and allied health professionals alike. Covering key topics in respiratory medicine from across the spectrum of disease areas including TB, lung cancer, chronic and acute respiratory failure, sleep breathing disorders, interstitial lung diseases, pneumonia, cystic fibrosis, COPD and asthma, amongst others, the congress programme is set to deliver the best advances in both science and education. This years’ congress will specifically highlight the importance of environment in respiratory health and focus on the need to personalise medicine in the respiratory arena. Special attention will also be paid to our interactions with microorganisms in our environment as well as those that live in peace within our organism.

Kamada to participate in 78th Scientific Sessions ADA

The Scientific Sessions offers researchers and health care professionals an amazing opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care. Over the course of five days, attendees will receive exclusive access to more than 2,800 original research presentations, take part in provocative and engaging exchanges with leading diabetes experts, and expand professional networks with nearly 13,000 professional attendees from around the world.

Kamada to participate in 2018 BIO International Convention

The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. The key benefits of attending the 2018 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry though-leaders with over 500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 74 countries.

Kamada to participate in Respiration Day

Respiration Day is a highly scientific, international event, reserved to physicians and researchers who meet annually to exchange ideas and experiences and to be updated on the latest outcomes of the worldwide biomedical research in respiratory diseases. The aim of the 2018 edition of “Respiration Day” is to provide the view of where the Respiratory clinicians and researchers community is, and where it needs to go in the evolving era of personalized medicine.

Kamada to participate in ATS 2018 conference

The congress is expected to attract over 17,000 clinical investigators, scientists and medical professionals related to the fields of sleep medicine pulmonary, and critical care. Aimed at displaying and delivering the educational sessions about recent advancements in research related to Pneumology the conference will show-up as a benchmark and turning point for the medical personnel.

Kamada to host First Qurter 2018 Financial Results Conference Call on May 15 2018

Direct webcast link:http://public.viavid.com/index.php?id=129156 Kamada management will host an investment community conference call on Tuesday, May 15 at 8:30am Eastern Time, to discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 866-548-4713  (from within the U.S.), 1 80 924 3003 (from Israel), or 323-794-2423 (International) and entering the conference identification number: 2302061. The call will also be webcast live on the Internet on the Company’s website at www.kamada.com. A replay of the call will be accessible two hours after its completion through May 29 by dialing 844-512-2921 (from within the U.S.) or 412-317-6671 (from outside the U.S.) and entering the conference identification number: 2302061. The call will also be archived for 90 days on the Company’s website at www.kamada.com.

Kamada to participate in 19th Annual Israeli Conference – Oppenheimer Israel

Oppenheimer Israel is the leading provider of global brokerage services to the Israeli Institutional market. The established Tel-Aviv based office is operating for more than 40 years and employs professionals in brokerage, research and executive services. Supported by the Oppenheimer USA group, Oppenheimer Israel services the leading Israeli financial institutions: Banks, Brokers, Insurance Companies, Pension funds, Hedge Funds, Mutual funds and Portfolio Managers.

Kamada to participate in the 7th Northern European Conference on Travel Medicine (NECTM7)

The NECTM7 conference will reflect the multi-disciplinary nature of travel health from the basic knowledge to the latest research and including both nurses, clinicians, academics and students.

Kamada to participate in H. C. Wainwright Global Biotechnology Conference

H.C. Wainwright & Co. is one of the country’s oldest and leading financial institutions. Their  services are tailored to meet the clients’ needs and their expertise spans a wide range of industries and organizations. They are devoted to building long-term relationships with clients and find that many of the clients seek their services on a repeated basis.